Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid

Trial Profile

Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Perflubutane (Primary)
  • Indications Liver cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 12 Sep 2017 Planned initiation date changed from 1 Mar 2017 to 1 Oct 2017.
    • 12 Sep 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 29 Mar 2017 Planned initiation date changed from 1 Mar 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top